All Bout Corps’ Post

Sova Health, a pioneering startup in gut health, has secured $1 million in a seed funding round. This round was co-led by global early-stage venture capital firms Antler, Accelerating Asia Ventures (Singapore), Practical VC (USA), and VC Grid & Venture Catalysts (India). Additional investors include Quadrant Consumer Products and Midas Capital (Baheti Family Office), along with several prominent angel investors who remain undisclosed. The newly acquired funds will be allocated to product development, enhancing Sova Health's range of gut health solutions. The startup also plans to grow its team and expand its geographical market presence. Part of the investment will be directed towards launching a clinical trial for Sova Health’s Digital Therapeutics (DTx) program, reinforcing the company’s dedication to scientific research and product effectiveness. Founded by Tanveer Singh and Max Kushnir, Sova Health addresses various gut health issues such as irritable bowel syndrome (IBS), acidity, constipation, and bloating. Sova Health offers direct-to-consumer gut microbiome tests and a proprietary line of probiotic supplements. Additionally, they provide customized gut health programs tailored for individuals with gastrointestinal conditions like IBS, IBD, GERD, Crohn’s Disease, and chronic acidity. Their comprehensive approach integrates gut biome diagnostics, probiotics, and nutritional therapy to alleviate symptoms and promote remission. Prior to this seed round, Sova Health received pre-seed funding from notable investors including Goodwater Capital, Brinc, IIMA Ventures, and Stanford Angels & Entrepreneurs. #SovaHealth #GutHealth #HealthTech #SeedFunding #FundingAlert #Funding #FundraiserAlert #VentureCapital #Probiotics #Microbiome #DigitalTherapeutics #IBS #IBD #GERD #CrohnsDisease #Constipation #Acidity #NutritionalTherapy #ProductDevelopment #HealthInnovation #ClinicalTrials #Investment #HealthStartups #AngelInvestors #AllBoutCorps

  • No alternative text description for this image
Vishal Jain

Co-Founder & COO @ Misfits

8mo

Congratulation, Tanveer Singh & Max Kushnir. Onwards and Upwards. 🚀

Roei Mazor, MD, PhD

VP Clinical Development & Medical Affairs at Canopy Immunotherapeutics

8mo

Congratulations!

Inbal Latner

GTM & Growth | VP Product | Fractional Leadership

8mo

Congratulations Max Kushnir and Tanveer Singh !

Anita Hangloo

Techno-Commercial Business Development (International &Domestic)

8mo

Congratulations!

Varun Kumar

UX Architect at HCL Technologies

8mo

Congratulations! Tanveer

See more comments

To view or add a comment, sign in

Explore topics